Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): Methodology of a pragmatic, response-adaptive, prospective randomized clinical trial.
Benjamin T KingPatrick D LawrenceTruman J MillingSteven J WarachPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
The optimal timing of direct oral anticoagulants post-ischemic stroke requires prospective randomized testing. A pragmatically designed trial with adaptive allocation and randomization to multiple time intervals such as the START trial is best suited to answer this question in order to directly inform current practice on this question.
Keyphrases
- atrial fibrillation
- direct oral anticoagulants
- phase iii
- phase ii
- study protocol
- double blind
- venous thromboembolism
- open label
- oral anticoagulants
- catheter ablation
- clinical trial
- left atrial
- left atrial appendage
- placebo controlled
- heart failure
- healthcare
- primary care
- percutaneous coronary intervention
- randomized controlled trial
- quality improvement
- coronary artery disease